Robotaxi faces another safety test: Waymo recalls nearly 3,800 vehicles due to the risk of encountering standing water.
The National Highway Traffic Safety Administration (NHTSA) announced on Tuesday that Waymo will be recalling 3,791 self-driving taxis in the United States, as its autonomous driving software has defects that could cause the vehicles to drive into flooded roads.
The National Highway Traffic Safety Administration (NHTSA) announced on Tuesday that Waymo is recalling 3791 Siasun Robot & Automation taxis in the United States due to defects in its autonomous driving software that may cause the vehicles to enter flooded roads.
The recall involves vehicles with the fifth and sixth generation autonomous driving systems (ADS).
As a temporary measure, Waymo has modified its operating range by adding weather-related restrictions and updating maps. A complete fix is currently being developed.
From a technical perspective, flooded roads are typical "long-tail complex scenarios" for autonomous driving systems. In such situations, cameras may be affected by glare, there is a risk of misjudgment in water surface recognition by LiDAR, and static maps cannot reflect real-time road condition changes, making it easier for vehicles to deviate in perception and decision-making. These extreme scenarios have long been considered a significant technological bottleneck for the scaled operation of Robotaxis.
It is worth noting that as Robotaxi commercialization progresses, U.S. regulatory agencies are gradually strengthening their review of the safety of autonomous driving systems. The industry is transitioning from the early stage of technology validation into a phase of continuous regulation and responsibility definition. Analysts believe that as operational scale expands, the cost pressure on autonomous driving companies in software validation, remote monitoring, and compliant operation may further increase.
Additionally, Waymo has recently faced multiple safety-related investigations. In January of this year, one of its autonomous vehicles hit a child near a school in Santa Monica, California. Last month, the National Transportation Safety Board (NTSB) stated it was investigating an incident in January where a Waymo autonomous vehicle violated Texas state law by passing a stopped school bus with its lights flashing.
As a subsidiary of Alphabet Inc. (GOOGL.US), Waymo has long been seen as one of the leading companies in global Robotaxi commercialization, and its technological path is often seen as a benchmark in the industry. However, this recall event once again shows that even top companies find it difficult to completely avoid the complex and highly uncertain operational environment risks on real roads.
Industry Comparison: Tesla, Inc. Faces Similar Challenges
Similar issues are not unique to Waymo. Tesla, Inc. has also faced regulatory scrutiny in recent years due to issues with its autonomous and assisted driving systems.
In 2023, Tesla, Inc. recalled approximately 2 million vehicles due to defects in the Autopilot driver monitoring system, making it one of the largest recalls in U.S. history related to autonomous driving software. Regulatory agencies believe that this system may cause drivers to overly rely on the assisted driving function, increasing the risk of accidents.
Since then, the system has continued to face effectiveness reviews and safety concerns.
Analysts point out that both Waymo's Robotaxi and Tesla, Inc.'s assisted driving systems reflect that the autonomous driving industry is still in a stage of incomplete maturity in handling complex road environments, long-tail scenarios, and the division of responsibility between humans and machines.
Related Articles

ZYLOXTB(02190) spent approximately HKD 1.1362 million to repurchase 51,000 shares on May 12th.

PW MEDTECH (01358) spent 992,000 Hong Kong dollars to repurchase 841,000 shares on May 12th.

CIG Shanghai (06166) will distribute a final dividend of $0.28 per share on June 25th.
ZYLOXTB(02190) spent approximately HKD 1.1362 million to repurchase 51,000 shares on May 12th.

PW MEDTECH (01358) spent 992,000 Hong Kong dollars to repurchase 841,000 shares on May 12th.

CIG Shanghai (06166) will distribute a final dividend of $0.28 per share on June 25th.

RECOMMEND

Two Mainland Accounting Firms Approved for H‑Share Audits, Lowering Listing Costs and Deepening Mainland–Hong Kong Market Integration**The Ministry of Finance, the CSRC, and Hong Kong’s Accounting and Financial Reporting Council have approved two additional mainland accounting firms—RSM China and ShineWing—to conduct H‑share audit work, marking the first expansion of the list since 2010.
11/05/2026

HKEX Tightens Rules on Auditor Dismissals as Sudden “Audit Firm Switches” Raise Governance Concerns
11/05/2026

The Chip Stock Frenzy Is Still Accelerating
11/05/2026


